Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. The firm operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Who is the CEO of Teva Pharmaceutical Industries Limited?
Mr. Richard Francis is the President of Teva Pharmaceutical Industries Limited, joining the firm since 2023.
What is the price performance of Teva Pharmaceutical Industries stock?
The current price of Teva Pharmaceutical Industries is $29.98, it has increased 5.76% in the last trading day.
What are the primary business themes or industries for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited belongs to Pharmaceuticals industry and the sector is Health Care
What is Teva Pharmaceutical Industries Limited market cap?
Teva Pharmaceutical Industries Limited's current market cap is $34.9B
Is Teva Pharmaceutical Industries Limited a buy, sell, or hold?
According to wall street analysts, 3 analysts have made analyst ratings for Teva Pharmaceutical Industries Limited, including 0 strong buy, 0 buy, 3 hold, 4 sell, and 0 strong sell